Lockheed, Martin

Lockheed Martin Shares: A Tale of Strong Orders and Future Caution

23.12.2025 - 09:34:04

Lockheed US5398301094

The defense giant Lockheed Martin finds itself at an interesting crossroads. Recent weeks have delivered significant contract wins and a key technological milestone, yet these positive developments are being weighed against longer-term financial concerns raised by market analysts. This creates a clear narrative tension between present strength and future uncertainty.

Despite robust operational performance, a note of caution emerged from Wall Street. On December 19, analysts at JPMorgan revised their rating on Lockheed Martin's stock from "Overweight" to "Neutral." Intriguingly, they simultaneously raised their price target to $515 per share.

The rationale for this more cautious stance centers on anticipated pressures on free cash flow, particularly from expected pension funding requirements beginning in 2027. JPMorgan's assessment suggests that while demand for the company's products remains solid, the trajectory for free cash flow growth is likely to be flatter than previously assumed. This long-view concern forms a counterpoint to the immediate positive news.

Major Space Agency Contract Bolsters Backlog

In a significant boost to its space segment, Lockheed has secured a substantial new award from the U.S. Space Development Agency (SDA). The firm-fixed-price contract, with a potential value exceeding $1 billion, covers the production of 18 spacecraft for the Tranche 3 Tracking Layer (TRKT3).

These satellites are designed for advanced missile warning, tracking, and defense, with a planned launch date in fiscal year 2029. The system aims to provide global coverage against modern missile threats, including hypersonic weapons. This award significantly expands Lockheed's role in the Proliferated Warfighter Space Architecture, bringing its total SDA commitment to 124 spacecraft. For the company's space division, this translates into high revenue visibility and a more predictable multi-year backlog.

Extended-Range Rocket System Proves Its Mettle

Parallel to its space achievements, Lockheed has demonstrated progress in its tactical missile portfolio. The company successfully tested its Extended-Range Guided Multiple Launch Rocket System (ER GMLRS), achieving a striking distance of 112 kilometers at the White Sands Missile Range.

Launched from a High Mobility Artillery Rocket System (HIMARS) launcher, this range is nearly double that of the standard GMLRS variant, confirming a major extension in operational reach. The test also validated the precision and effectiveness of the system's alternative warhead—a key factor for future procurement decisions by the U.S. Army and international clients. This advancement shows Lockheed is actively pushing performance boundaries within existing programs to position itself for follow-on contracts.

Should investors sell immediately? Or is it worth buying Lockheed?

Quarterly Results Show Current Strength

Lockheed's most recent financial report, covering the third quarter of 2025, underscored its present operational health. Earnings per share came in at $6.95, comfortably surpassing the consensus estimate of $6.33. Revenue reached $18.61 billion, marking an 8.8% increase compared to the same period last year.

For the full 2025 fiscal year, management has provided EPS guidance in the range of $22.15 to $22.35. These figures highlight the company's robust current order book and execution capabilities, even amidst the longer-term financial caveats noted by analysts.

Key Data Points:
* New SDA contract valued over $1 billion for 18 tracking satellites; launch target 2029.
* Total SDA spacecraft commitment now stands at 124 units.
* ER GMLRS test confirms extended operational range of 112 km.
* Q3 2025 EPS: $6.95 (above the $6.33 expectation).
* Q3 2025 Revenue: $18.61 billion, up 8.8% year-over-year.
* JPMorgan rating: Downgraded to "Neutral"; price target set at $515.

Market Reaction and the Path Forward

The market's reaction to this mixed picture has been measured. The share price, trading around €411, remains just above its 50- and 200-day moving averages and approximately 15% below its 52-week high. This indicates an absence of panic but also a lack of clear bullish momentum.

The situation is now well-defined. On one side, there are multibillion-dollar new contracts, technological advances, and quarterly earnings that beat expectations. On the other, analysts advise prudence regarding future pension liabilities and a potentially less dynamic free cash flow profile post-2027.

In the near term, the additional SDA backlog exceeding $1 billion should enhance visibility for the space division and support earnings. The medium- to long-term story, however, will hinge on Lockheed's ability to offset the anticipated cash flow pressures through additional high-margin programs and efficient capital management.

Ad

Lockheed Stock: Buy or Sell?! New Lockheed Analysis from December 23 delivers the answer:

The latest Lockheed figures speak for themselves: Urgent action needed for Lockheed investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 23.

Lockheed: Buy or sell? Read more here...

@ boerse-global.de